Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Periradicular meloxicam injection versus physiological solution for lumbar and/or sacral radiculitis
2009-016684-11Phase 2Active
- Sponsor
- Istituto Ortopedico Rizzoli
- Start
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of meloxicam in lumbosacral radiculopathy, sacral radiculitis and Sciatica (2 arms), sponsored by Istituto Ortopedico Rizzoli. Primary endpoint: Analgesic evaluation of meloxicam versus physiological solution. Started Aug 2010; status: active.
02
Drugs
meloxicam
03
Conditions
lumbosacral radiculopathysacral radiculitisSciatica
Beyond the preview
Go deeper on 2009-016684-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016684-11.